Andy Pasternak
2020
In 2020, Andy Pasternak earned a total compensation of $5.8M as Executive Vice President, Chief Strategy Officer at Horizon Pharma, a 99% increase compared to previous year.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Non-Equity Incentive Plan | $802,825 |
| Salary | $669,021 |
| Stock Awards | $4,037,409 |
| Other | $66,872 |
| Total | $5,826,126 |
Pasternak received $4M in stock awards, accounting for 69% of the total pay in 2020.
Pasternak also received $250K in bonus, $802.8K in non-equity incentive plan, $669K in salary and $66.9K in other compensation.
Rankings
In 2020, Andy Pasternak's compensation ranked 1,820th out of 13,090 executives tracked by ExecPay. In other words, Pasternak earned more than 86.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,820 out of 13,090 | 86th |
Division Manufacturing | 703 out of 5,621 | 88th |
Major group Chemicals And Allied Products | 254 out of 2,254 | 89th |
Industry group Drugs | 213 out of 1,954 | 89th |
Industry Pharmaceutical Preparations | 151 out of 1,459 | 90th |
Pay ratio
| Andy Pasternak's Pay | $5,826,126 |
|---|---|
| Median Employee's Pay | $298,446 |
| Pay Ratio | 20to 1 |
In 2020, the annual total compensation of Andy Pasternak was $5,826,126.
The annual total compensation of the median employee at Horizon Pharma was $298,446.
The ratio of Andy Pasternak's pay to the pay of median employee was therefore 20 to one.
Source: SEC filing on March 17, 2021.
Pasternak's colleagues
We found five more compensation records of executives who worked with Andy Pasternak at Horizon Pharma in 2020.